Are your symptomatic obstructive HCM patients asking about treatment options?

Sponsored by Bristol Myers SquibbLearn about a treatment option for NYHA Class II-III obstructive HCM

PAID ADVERTISEMENT

For patients with NYHA Class II-III obstructive HCM, there is a treatment option available. Review the clinical data and MOA of a treatment option that has been evaluated for its impact on symptoms and exercise capacity, and LVOT obstruction. 

Click here to download